CINGAL®

Product Information

• Active ingredient: Hyaluronic acid, triamcinolone hexacetonide
• Strength: 88 mg/4 ml HA, 18 mg/4 ml triamcinolone hexacetonide
• Package content: 1 x 4 ml pre-filled syringe
• Manufacturer: Anika Therapeutics
• Brand: CINGAL®
• Category: Orthopedic Injections

CINGAL® Dosage and Administration

CINGAL® is available in:

• A single-use, prefilled syringe containing 4 ml of injectable solution.

Administration guidelines:

• Injection should be performed intra-articularly directly into the knee joint.
• Standard protocol involves one injection per affected joint.
• Procedure should be conducted under strict aseptic conditions by trained healthcare professionals experienced in joint injections.
• Post-injection patient monitoring is recommended to assess tolerance and response.

Ingredient Information

CINGAL® combines two active ingredients for maximum therapeutic effectiveness:

• Hyaluronic Acid (HA): Provides long-term joint lubrication and cushioning, significantly improving joint function.
• Triamcinolone Hexacetonide (Corticosteroid): Quickly reduces inflammation and provides rapid symptom relief.

This dual-action formula effectively addresses both immediate discomfort and sustained joint health.

Storage Instructions

• Store CINGAL® between 2°C and 25°C.
• Protect from direct sunlight, freezing, and excessive moisture.
• Keep in original sealed packaging until ready for use.
• Do not use if the packaging appears compromised or after the expiration date.

Proper storage ensures maximum safety, effectiveness, and reliability.

CINGAL® Contraindications

Avoid use of CINGAL® in patients who:

• Are pregnant or breastfeeding.
• Have known allergies or hypersensitivity to hyaluronic acid, corticosteroids, or other formulation components.
• Present active infections, skin diseases, or open wounds at the intended injection site.
• Suffer from bleeding disorders or those currently on anticoagulant therapy without prior medical consultation.

CINGAL® Precautions and Warnings

• Administer CINGAL® injections exclusively by licensed medical professionals experienced in intra-articular treatments.
• Conduct thorough patient evaluations including medical history, allergies, and current medications.
• Avoid injecting into blood vessels or tissues other than intra-articular spaces to prevent adverse reactions.
• Advise patients clearly about potential side effects and necessary post-treatment care measures.

CINGAL® Manufacturer and Regulatory Information

CINGAL® is manufactured by Anika Therapeutics, a global leader specializing in therapeutic products based on hyaluronic acid technology.

• Supplied for professional use in accordance with applicable regulations.
• Produced under stringent quality control measures to ensure patient safety and product efficacy.
• Widely trusted by healthcare providers globally for effective osteoarthritis treatment.

Healthcare professionals who order CINGAL from Kinami Health benefit from guaranteed authenticity, premium product quality, and comprehensive professional support, enhancing treatment outcomes and patient satisfaction.

Buying CINGAL® in Canada

Kinami Health supplies genuine CINGAL® to licensed healthcare professionals and clinics across Canada, sourced through verified channels and delivered in sealed original packaging with a traceable LOT number, with wholesale pricing and fast delivery.

In Canada, who may administer intra-articular injections varies by province and professional college; practitioners should follow the rules that apply in their own jurisdiction. Adverse reactions can be reported to Health Canada.

Explore the full CINGAL® range or compare other products in the Orthopedic Injections category.